Evidence profile
5-Amino-1MQ (50 mg Vial)
5-Amino-1MQ is a small-molecule NNMT inhibitor studied in experimental metabolic models.
01
Product identity
It is a small molecule rather than a peptide.
Counter-ion and chemical form matter when matching a study or interpreting reported mass.
02
What has been studied
Primary preclinical study
Metabolic studies in mice
- Population or model
- Diet-induced obese mice
- Study route or material
- Experimental mouse dosing and pharmacokinetic methods
Researchers studied NNMT inhibition and metabolic measurements in diet-induced obese mice.[1]
Primary analytical/preclinical study
Analytical and exposure measurements
- Population or model
- Rat plasma, urine and in vivo pharmacokinetics
- Study route or material
- Intravenous and oral animal methods
A separate study developed an assay and measured exposure in rats. These measurements help characterize the compound, but do not establish a clinical treatment.[2]
03
Evidence limits
A human dose, treatment benefit and long-term safety assessment have not been established in this source review.
The reviewed sources do not establish patient instructions for this product. No dose, cycle, preparation method or administration schedule is provided here.
04
Formulation and handling evidence
Exact chemical and salt form with quantitative content.
Product-specific solubility, compatible vehicle and storage documentation.
A compatible diluent, prepared-solution stability and container/device compatibility must be supported for the exact formulation. The diluent manufacturer’s instructions do not supply a universal storage period for every dissolved substance.[4]
05
Approval context
This profile has not established Canadian authorization of the linked research product.[3]
06
Sources and review scope
- 5A1MQ in diet-induced obese micePrimary preclinical study · Abstract and indexed identity · Checked 2026-09-08
- 5-amino-1-methylquinolinium assay and rat pharmacokineticsPrimary analytical/preclinical study · Abstract and indexed identity · Checked 2026-09-08
- Health Canada: unauthorized injectable peptide productsRegulatory advisory · Fresh Health Canada advisory read, including product/DIN and RUO-label limits · Checked 2026-09-09
- Hospira/Pfizer: bacteriostatic water manufacturer informationManufacturer information; US presentation · Fresh manufacturer page, relevant compatibility/storage/supply passages · Checked 2026-09-09
- Amino Labs: 5-Amino-1mq | 50mgSupplier listing; identity reference · Exact heading, SKU, form and supplier URL from the full catalogue capture; not stock-lot authentication · Checked 2026-09-09
This is a selected-source evidence summary. It is not a systematic review, formal certainty grade or qualified clinical sign-off. Study dates and source-check dates are distinct.